| Dr. Michael Wright, Lcsw | |
|
9 Field St Ste 108 Belfast ME 04915-6661 | |
| (207) 387-0691 | |
| Not Available |
| Full Name | Dr. Michael Wright, Lcsw |
|---|---|
| Speciality | Community/Behavioral Health |
| Location | 9 Field St Ste 108, Belfast, Maine |
| Authorized Official Name and Position | Michael T Wright (OWNER) |
| Authorized Official Contact | 2073870961 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Dr. Michael Wright, Lcsw 9 Field St Ste 108 Belfast ME 04915-6661 Ph: (207) 387-0691 | Dr. Michael Wright, Lcsw 9 Field St Ste 108 Belfast ME 04915-6661 Ph: (207) 387-0691 |
| NPI Number | 1689144099 |
|---|---|
| Provider Enumeration Date | 11/28/2018 |
| Last Update Date | 10/24/2022 |
| Certification Date | 10/24/2022 |
| Medicare PECOS PAC ID | 3173869831 |
|---|---|
| Medicare Enrollment ID | O20230206000576 |
News Archive
Most primary care physicians (PCPs) and kidney specialists favor collaborative care for a patient with progressive chronic kidney disease (CKD), but their preferences on how and when to collaborate differ, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). PCPs and kidney specialists need to partner more effectively to optimize care for patients with CKD.
Developments in nanotechnology and nanorobotics are opening up the prospects for nanomedicine and regenerative medicine where informatics and DNA computing can become the catalysts enabling health care applications at sub-molecular or atomic scales. While nanomedicine promises a new exciting frontier for clinical practice and biomedical research, issues involving cost-effectiveness studies, clinical trials and toxicity assays, drug delivery methods, and the implementation of new personalized therapies still remain challenging.
AMICAS, Inc., a leader in image and information management solutions, today announced that it has received from Merge Healthcare Incorporated a proposal to acquire all of the outstanding shares of AMICAS for $6.05 per share in cash, which has been updated to include an executed definitive commitment letter for $200 million of financing from Morgan Stanley and confirmation that Merge will place a portion of the pre-funded proceeds received from its mezzanine investors into an escrow account directly accessible by AMICAS.
BIOTRONIK SE & Co. KG, the pioneer of wireless remote monitoring technologies and leading manufacturer of implantable cardiac devices, today announced the first implantations of BIOTRONIK's new leadless cardiac monitoring device performed by a team of physicians led by Professor Dr. Gerhard Hindricks, Director, Electrophysiology Department at the Leipzig Heart Center in Leipzig, Germany.
When children undergo anesthesia during surgery, the long-term effects that anesthetics have on the developing brain is relatively unknown. A study presented at this year's American Society of Anesthesiologists Annual Meeting assesses the association between exposure to anesthesia in children 3 years old and younger and their risk for developmental and behavioral disorders.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689144099 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 251S00000X | Community/behavioral Health | (* (Not Available)) | Primary |
| Provider Name | Michael T Wright |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1659862142 PECOS PAC ID: 4082950746 Enrollment ID: I20230206000553 |
News Archive
Most primary care physicians (PCPs) and kidney specialists favor collaborative care for a patient with progressive chronic kidney disease (CKD), but their preferences on how and when to collaborate differ, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). PCPs and kidney specialists need to partner more effectively to optimize care for patients with CKD.
Developments in nanotechnology and nanorobotics are opening up the prospects for nanomedicine and regenerative medicine where informatics and DNA computing can become the catalysts enabling health care applications at sub-molecular or atomic scales. While nanomedicine promises a new exciting frontier for clinical practice and biomedical research, issues involving cost-effectiveness studies, clinical trials and toxicity assays, drug delivery methods, and the implementation of new personalized therapies still remain challenging.
AMICAS, Inc., a leader in image and information management solutions, today announced that it has received from Merge Healthcare Incorporated a proposal to acquire all of the outstanding shares of AMICAS for $6.05 per share in cash, which has been updated to include an executed definitive commitment letter for $200 million of financing from Morgan Stanley and confirmation that Merge will place a portion of the pre-funded proceeds received from its mezzanine investors into an escrow account directly accessible by AMICAS.
BIOTRONIK SE & Co. KG, the pioneer of wireless remote monitoring technologies and leading manufacturer of implantable cardiac devices, today announced the first implantations of BIOTRONIK's new leadless cardiac monitoring device performed by a team of physicians led by Professor Dr. Gerhard Hindricks, Director, Electrophysiology Department at the Leipzig Heart Center in Leipzig, Germany.
When children undergo anesthesia during surgery, the long-term effects that anesthetics have on the developing brain is relatively unknown. A study presented at this year's American Society of Anesthesiologists Annual Meeting assesses the association between exposure to anesthesia in children 3 years old and younger and their risk for developmental and behavioral disorders.
› Verified 6 days ago
News Archive
Most primary care physicians (PCPs) and kidney specialists favor collaborative care for a patient with progressive chronic kidney disease (CKD), but their preferences on how and when to collaborate differ, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). PCPs and kidney specialists need to partner more effectively to optimize care for patients with CKD.
Developments in nanotechnology and nanorobotics are opening up the prospects for nanomedicine and regenerative medicine where informatics and DNA computing can become the catalysts enabling health care applications at sub-molecular or atomic scales. While nanomedicine promises a new exciting frontier for clinical practice and biomedical research, issues involving cost-effectiveness studies, clinical trials and toxicity assays, drug delivery methods, and the implementation of new personalized therapies still remain challenging.
AMICAS, Inc., a leader in image and information management solutions, today announced that it has received from Merge Healthcare Incorporated a proposal to acquire all of the outstanding shares of AMICAS for $6.05 per share in cash, which has been updated to include an executed definitive commitment letter for $200 million of financing from Morgan Stanley and confirmation that Merge will place a portion of the pre-funded proceeds received from its mezzanine investors into an escrow account directly accessible by AMICAS.
BIOTRONIK SE & Co. KG, the pioneer of wireless remote monitoring technologies and leading manufacturer of implantable cardiac devices, today announced the first implantations of BIOTRONIK's new leadless cardiac monitoring device performed by a team of physicians led by Professor Dr. Gerhard Hindricks, Director, Electrophysiology Department at the Leipzig Heart Center in Leipzig, Germany.
When children undergo anesthesia during surgery, the long-term effects that anesthetics have on the developing brain is relatively unknown. A study presented at this year's American Society of Anesthesiologists Annual Meeting assesses the association between exposure to anesthesia in children 3 years old and younger and their risk for developmental and behavioral disorders.
› Verified 6 days ago
Partners For Change Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 37 E Trout Lane, Belfast, ME 04915 Phone: 207-338-6055 Fax: 207-338-6038 | |
Emplowers Employment Options Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 111 Church St, Second Floor, Belfast, ME 04915 Phone: 207-542-3388 | |
Emily Hill Lcsw Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 9 Field St Ste 101, Belfast, ME 04915 Phone: 207-322-0785 | |
Mental Health Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 9 Field St, Suite 206, Belfast, ME 04915 Phone: 207-338-9145 | |
Lydia Hall Lcsw, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 26 Spring St, Belfast, ME 04915 Phone: 207-602-0005 | |
Benjamin Borkan Lcsw Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 26 Spring St, Belfast, ME 04915 Phone: 207-370-2454 Fax: 207-888-2842 |